Name: ＷＥＳＴＯＮ（ウエストン）３３０ グラボノイド
Brand: 株式会社リマックスジャパン
Availability: Discontinued

A193

ＷＥＳＴＯＮ（ウエストン）３３０　グラボノイド

株式会社リマックスジャパン

販売休止中

加工食品(錠剤、カプセル剤等)

Functional Claim

本品は3%グラブリジン含有甘草抽出物を含みます。3%グラブリジン含有甘草抽出物は、お腹の脂肪（内臓脂肪）・体脂肪を減らす働きがあり、高めのBMIの改善に役立つことが報告されています。体脂肪が気になる方、肥満気味の方に適しています。

AI Summary

Automatically generated from notification documents

This functional food contains licorice extract with 3% glabridin, which has been reported to help reduce abdominal (visceral) fat and body fat, and support improvement of higher BMI levels.

Key Features

[

"

R

e

d

u

c

e

s

v

i

s

c

e

r

a

l

f

a

t

"

,

"

I

m

p

r

o

v

e

s

h

i

g

h

e

r

B

M

I

"

,

"

C

o

n

t

a

i

n

s

g

l

a

b

r

i

d

i

n

"

]

For those concerned about body fat, visceral fat, or weight management.

Recommended Products

PR

広告: A8.net

Notification Documents

Product Name	ＷＥＳＴＯＮ（ウエストン）３３０　グラボノイド
Category
Food Classification	加工食品(錠剤、カプセル剤等)
Functional Ingredient Name	3%グラブリジン含有甘草抽出物
Functional ingredient is an extract	No
Functional Claim	本品は3%グラブリジン含有甘草抽出物を含みます。3%グラブリジン含有甘草抽出物は、お腹の脂肪（内臓脂肪）・体脂肪を減らす働きがあり、高めのBMIの改善に役立つことが報告されています。体脂肪が気になる方、肥満気味の方に適しています。
Consumer Affairs Department Contact
Information Disclosure Website URL

1. Basic Safety Information

(1) Precautions for Intake
(2) Safety Evaluation Method
(3) Notifier's Safety Evaluation

2. Production, Manufacturing & Quality Control

Details

3. Basic Functionality Information

(1) Functionality Evaluation Method
(2) Notifier's Functionality Evaluation

4. Other Notification Items

Reason for not classifying as tablet/capsule food
Primary Target Audience
Planned Sales Start Date
Change History (before Mar 31, 2025)
Change History (from Apr 1, 2025)
Before/After Comparison Table
Before/After Comparison Table (attachments)
If re-notification	No
Existing Notification Number
Reason for Maintaining Identity
Post-notification Sales Status	販売休止中
Reason for Notification Withdrawal

5. Self-Inspection Report

Month of Last Self-Inspection Report